Osteoporosis

Fracture and mortality risks for men aged 80 years or older have different profiles, and an assessment of both could help to inform osteoporosis drug treatment decisions, according to a speaker.

Variables added to adjust the Fracture Risk Assessment Tool for recent fractures overestimated risk in a cohort of older women from Canada, according to a speaker.

An effective way to predict a woman aged 25 to 31 years will develop osteoporosis is to do a check of sclerostin and possibly other blood serum markers for bone turnover at key timepoints in the woman’s life, according to a presenter.

A speaker at the 2021 Congress of Clinical Rheumatology-West shared how some osteoporosis guidelines conflict, leading to debates in the management of the disease.

Alendronate, a drug commonly used to treat osteoporosis, may help protect against type 2 diabetes, according to a presenter at the European Association for the Study of Diabetes virtual meeting.

A study of provider prescribing patterns revealed patients with advanced chronic kidney disease, especially those on dialysis, had lower rates of osteoporosis treatment than patients with earlier stages of kidney disease.

Discrepancies between clinical practice guideline documents highlight the over-arching controversies in osteoporosis management, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

People with diabetes and less appendicular skeletal muscle mass are more likely to have lower bone mineral density in the lumbar spine, hip and femoral neck and are at a greater risk for osteoporosis, according to study data.

New research showed that absolute appendicular lean mass may help predict osteoporosis in postmenopausal women. It was the top story in endocrinology last week.

NAMS has released a position statement reflecting the latest thinking and findings regarding the management of osteoporosis in postmenopausal women.